Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show, Webcast

BeiGene to Present at the Morgan Stanley 18th Annual Global Healthcare Conference


BeiGene, Ltd. (NASDAQ:BGNE; HKEX:06160), a commercial-stage biotechnology company focused on developing and commercializing innovative medicines worldwide, today announced that the Company will present at the Morgan Stanley 18th Annual Global Healthcare Conference on Thursday, September 17, 2020 at 11:45 a.m. ET.

A live webcast can be accessed from the investors section of BeiGene's website at http://ir.beigene.com or http://hkexir.beigene.com. An archived replay will be available following the event for 90 days.

About BeiGene

BeiGene is a global, commercial-stage biotechnology company focused on discovering, developing, manufacturing, and commercializing innovative medicines to improve treatment outcomes and access for patients worldwide. Our 4,200+ employees in China, the United States, Australia, Europe, and elsewhere are committed to expediting the development of a diverse pipeline of novel therapeutics. We currently market two internally discovered oncology products: BTK inhibitor BRUKINSA® (zanubrutinib) in the United States and China, and anti-PD-1 antibody tislelizumab in China. We also market or plan to market in China additional oncology products licensed from Amgen Inc., Celgene Logistics Sàrl, a Bristol Myers Squibb (BMS) company, and EUSA Pharma. To learn more about BeiGene, please visit www.beigene.com and follow us on Twitter at @BeiGeneUSA.


These press releases may also interest you

at 05:10
Since mild cognitive impairment (MCI) is the first visible sign of cognition slippage, and may indicate an Alzheimer's disease process at work in the brain, it is logical to attempt to halt or reverse it, says Leslie Norins, M.D., Ph.D., CEO of...

at 05:05
Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing best-in-class single-agent and combination therapies to treat non-alcoholic steatohepatitis (NASH) and other liver diseases, announced today the...

at 05:00
According to latest report "Enteral Feeding Tubes Market Product (Nasoenteric/Nasal Feeding Tube, Abdominal/Ostotomy Feeding Tube), Disease Condition (Cancer, Central Nervous System & Mental Health, Non-malignant Gastrointestinal  Disorders), Patient...

at 04:15
Cell and gene therapies represent the next great wave of therapeutic innovation and have led to the development of promising therapies worldwide. Veristat, a scientific minded clinical research organization, announced today the launch of their...

at 04:15
The COVID-19 pandemic has wreaked havoc on the global economy and threatened to undo decades of progress made in health care Health: A Political Choice ? Act Now, Together is the latest in a series of titles produced in collaboration with the World...

at 04:05
The global ketogenic diet market size is expected to reach USD 14.75 billion by 2027, according to a new report by Grand View Research, Inc., expanding at a CAGR of 5.5% from 2020 to 2027. The rising obese population across the globe is a crucial...



News published on 10 september 2020 at 09:05 and distributed by: